These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24378862)

  • 41. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?
    Meyers K; Kaynak Ö; Bresani E; Curtis B; McNamara A; Brownfield K; Kirby KC
    Int J Drug Policy; 2015 Jul; 26(7):670-4. PubMed ID: 25641258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
    Cottencin O; Rolland B; Karila L
    Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GHB and synthetic cathinones: clinical effects and potential consequences.
    Karila L; Reynaud M
    Drug Test Anal; 2011 Sep; 3(9):552-9. PubMed ID: 21960540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analytical toxicology of emerging drugs of abuse.
    Peters FT; Martinez-Ramirez JA
    Ther Drug Monit; 2010 Oct; 32(5):532-9. PubMed ID: 20814349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salvia divinorum: exposures reported to a statewide poison control system over 10 years.
    Vohra R; Seefeld A; Cantrell FL; Clark RF
    J Emerg Med; 2011 Jun; 40(6):643-50. PubMed ID: 19765944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigating the 'bath salt' panic: the rarity of synthetic cathinone use among students in the United States.
    Stogner JM; Miller BL
    Drug Alcohol Rev; 2013 Sep; 32(5):545-9. PubMed ID: 23718639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perception vs. reality: an investigation of the misperceptions concerning the extent of peer novel drug use.
    Sanders A; Stogner JM; Miller BL
    J Drug Educ; 2013; 43(2):97-120. PubMed ID: 25068165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.
    Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG
    Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New drugs].
    Kupferschmidt H
    Praxis (Bern 1994); 2012 Apr; 101(9):565-70; quiz 565. PubMed ID: 22535450
    [No Abstract]   [Full Text] [Related]  

  • 57. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
    Law R; Schier J; Martin C; Chang A; Wolkin A;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey.
    Göl E; Çok I
    Forensic Sci Int; 2019 Jan; 294():113-123. PubMed ID: 30502695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.